News
-
-
PRESS RELEASE
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - Temporary Interruption of Share Repurchase Prog
Alzchem Group AG temporarily interrupts its share repurchase programme in preparation for the Annual Shareholders Meeting on May 8, 2025, to ensure proper shareholder dividend payments -
-
PRESS RELEASE
Alzchem Group invites you to the Creatine Conference 2025: Munich is becoming a hotspot for creatine research
Alzchem Group organizes Creatine Conference 2025 in Munich, bringing together creatine experts for discussions on fatigue, women's health, cognitive performance, and more. Event in hybrid format allowing online attendance -
-
-
-
PRESS RELEASE
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052 - 9th Interim Report
Alzchem Group AG published its 9th Interim Report, revealing the acquisition of 8,730 shares as part of the share buyback program. Detailed information available on the company's website -
-
PRESS RELEASE
Alzchem Group AG: Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Alzchem Group AG discloses details of share buyback program. 7,217 shares acquired during February 3-7, 2025. Visit website for daily transaction info
